Clinical research

Open public recruiting

 ID  Research title Principal Investigator
Research Secretariat
Target
diseases
symptom
Status UMIN* Remarks
JORTC
-ONC05
(PIT-3)


A phase II trial of induction erlotinib followed by surgical resection in patients with pathologically confirmed stage IIIA-N2 EGFR mutated non-small cell lung cancer. Principal Investigator:
Morihito Okada
Hiroshima University

Research Secretariat:
Kazuya Takamochi
Juntendo University
Stage IIIA-N2 EGFR mutated, Non-small cell lung cancer Open
public
recruiting
UMIN
000026197
-
JORTC
-ONC07


Colonic stent for "Bridge to Surgery" prospective randomized controlled trial comparing treatment with non-stenting surgery in stage II/III obstructive colon cancer. Principal Investigator:
Yoshihisa Saida
Toho University Ohashi Medical Center

Research Secretariat:
Shuntaro Yoshida
University of Tokyo
Colorectal cancer Open
public
recruiting
UMIN
000026158
The Colonic Stent Safe Procedure Research Group
JORTC
-CAM03


Efficacy of Oral Administration of Cystine and Theanine in Colorectal Cancer Patients Undergoing Capecitabine based Adjuvant Chemotherapy after Surgery: Randomized, Double-blind, Placebo controlled, Phase-II Study Principal Investigator:
Takashi Tsuchiya M.D.,Ph.D.
Sendai City Medical Center Sendai Open Hospital

Research Secretariat:
Reo Hamaguchi M.D.
Research Hospital of the Institute of Medical Science, The University of Tokyo
Colorectal cancer Open
public
recruiting
UMIN
000024784
Ajinomoto Co., Inc.
JORTC-
ONC06
(STRSPH)
Multicenter prospective study of stereotactic body radiotherapy for untreated solitary primary hepatocellular carcinoma Principal Investigator:
Satoshi Ishikura, M.D.,Ph.D.
Koshigaya Municipal Hospital

Research Secretariat:
Tomoki Kimura, M.D.,Ph.D.
Hiroshima University Hospital
Atsuya Takeda, M.D.,Ph.D.
Ofuna Central Hospital
Untreated solitary primary hepatocellular carcinoma Open
public
recruiting
UMIN
000013011
National Cancer Center Research and Development Fund
JORTC
-ONC04
(CRES3T)
A multicentre,single arm,confirmatory trial to evaluate the effectiveness of induction CDDP plus TS-1 with concurrent radiotherapy(66Gy) followed by surgical resection in patients with superior sulcus tumor Principal Investigator:
Masahiro Tsuboi, M.D.,Ph.D.
National Cancer Center Hospital East

Research Secretariat:
Kazuya Takamochi, M.D.,Ph.D.
Juntendo University
Superior sulcus tumor Open
public
recruiting
UMIN
000014386
National Cancer Center Research and Development Fund
JORTC
-ONC03
(PIT-2)
A phase II trial of induction CDDP plus TS-1 with concurrent radiotherapy followed by surgical resection in patients with pathologically confirmed stage IIIA-N2 squamous-cell non-small cell lung cancer Principal Investigator:
Kenji Suzuki, M.D.,Ph.D.
Juntendo University

Research Secretariat:
Kazuya Takamochi, M.D.,Ph.D.
Juntendo University
Stage IIIA-N2 Squamous, Non-small cell lung cancer Open
public
recruiting
UMIN
000012413

Preinitiation

------


Completion of registration

 ID  Research title Principal Investigator
Research Secretariat
Target
diseases
symptom
Status UMIN* Remarks
JORTC
-PAL14
Efficacy of CGS-1 in Migraine Female Volunteers: Randomized, Single-blind, Placebo-controlled, Crossover Trial. Principal Investigator:
Research Secretariat:
Nobuyasu Kimura
Tokyo Clinic
Migraine completion
of
registration
UMIN
000028919
Kao Corporation
JORTC
-PAL12
The Frequency of Extrapyramidal Symptoms In Cancer Patients Who Receive Palliative Care. A Multi-Center, Observational Study.(FRESH study) Principal Investigator:
Hiroto Ishiki, M.D.
Research Hospital,The Institute of Medical Science,The University of Tokyo

Research Secretariat:
Satoru Iwase, M.D.,Ph.D.
Research Hospital,The Institute of Medical Science,The University of Tokyo
Extrapyramidal Symptoms completion
of
registration
UMIN
000019810
Japan Agency for Medical Research and Development
Phase-R
Japan PHarmacological Audit study of Safety and Efficacy in Real world Principal Investigator:
Isseki Maeda, M.D.,Ph.D.
Osaka University Graduate School of Medicine

Research Secretariat:
Kota Kihara, Bec.
Non-Profit Organization JORTC
Cancer completion
of
registration
UMIN
000013326
Japan Agency for Medical Research and Development
JORTC
-PAL08
Efficacy of duloxetine for cancer patients with neuropathic pain: Doubleblind, Randomized, Placebo controlled, exploratory trial Principal Investigator
/Research Secretariat:
Hiromichi Matsuoka, M.D.,Ph.D.
Kinki University, Faculty of Medicine
Cancer
Pain
completion
of
registration
UMIN
000017647
Japan Agency for Medical Research and Development
JORTC
-PAL04
Indomethacin oral spray for the analgesic effect of pain reduction in patient with oral mucositis due to cancer therapy: Randomized, double-blind, placebo-controlled phase II trial Principal Investigator
/Research Secretariat:
Hiroka Nagaoka, M.D.
University of Tsukuba Hospital
Patients
with oral mucisitis
due to
cancer
therapy
completion
of
registration
UMIN
000017664
Grant for Research Advancement on Palliative Medicine, Japanese Society for Palliative Medicine
JORTC
-CAM02
Efficacy of Oral AHCC Supplementation in Female Breast Cancer Patients undergoing Anthracycline and Taxane based Adjuvant chemotherapy: Randomized, Double-blind, Placebo controlled, Phase-II Study Principal Investigator:
Sho Hangai, M.D.
The University of Tokyo

Research Secretariat:
Satoru Iwase, M.D.,Ph.D.
Research Hospital,The Institute of Medical Science,The University of Tokyo
Patients receiving adjuvant chemotherapy for breast cancer completion
of
registration
UMIN
000015455
consignment study from Amino Up Chemical Co.,Ltd.
JORTC
-PAL07
Before-after study of efficacy of morphine for dyspnea in patients with chronic obstructive pulmonary disease Principal Investigator
/Research Secretariat:
Yoshinobu Matsuda,M.D.
National Hospital Organization Kinki-Chuo Chest Medical Center
dyspnea by COPD completion
of
registration
UMIN
000015288
The Research Funding for Longevity Science from National Center for Geriatric and Gerontology
JORTC
-ONC02
(PIT-1)
A randomized phase II trial of induction CDDP +PEM +BEV versus CDDP + PEM with concurrent radiotherapy followed by surgical resection in patients with pathologically confirmed stage IIIA-N2 non-squamous- cell non-small cell lung cancer Principal Investigator:
Morihito Okada, M.D.,Ph.D.
Hiroshima University

Research Secretariat:
Kazuya Takamochi, M.D.,Ph.D.
Juntendo University
Stage IIIA-N2 Non-squamous, Non-small cell lung cancer completion
of
registration
UMIN
000011941
JORTC
-PAL03
Randomized study of prochlorperazine for the prophylaxis of oxycodon induced nausea in patients with cancer related pain Principal Investigator
/Research Secretariat:
Yasushi Goto, M.D.,Ph.D.
National Cancer Center Hospital
Nausea by oxycodon completion
of
registration
UMIN
000012008
Japan Agency for Medical Research and Development
JORTC
-PAL01
Efficacy of olanzapine for relief of nausea with incomplete bowel obstruction in advanced cancer patient: pragmatic randomized controlled trial Principal Investigator
/Research Secretariat:
Keisuke Kaneishi, M.D.
Japan Community Healthcare Organization Tokyo Shinjuku Medical Center
Nausea with incomplete bowel obstruction completion
of
registration
UMIN
000010317
Japan Agency for Medical Research and Development
JORTC
-PAL05
Phase I study of safety of morphine for dyspnea in patients with interstitial lung disease Principal Investigator
/Research Secretariat:
Yoshinobu Matsuda, M.D.
National Hospital Organization Kinki-Chuo Chest Medical Center
dyspnea in patients with interstitial lung disease completion
of
registration
UMIN
000016137
Grant for Research Advancement on Palliative Medicine, Japanese Society for Palliative Medicine
JORTC
-KMP02
Efficacy of Rikkunshito on Nausea, Vomiting and Anorexia in Patients with Uterus Cancer Treated with Cisplatin plus Paclitaxel ? Randomized Phase II Study Principal Investigator:
Shunsuke Ohnishi, M.D.,Ph.D.
Hokkaido University

Research Secretariat:
Hidemichi Watari, M.D.,Ph.D.
Hokkaido University Hospital
Uterus
cancer
completion
of
registration
UMIN
000011227
・Grants-in-Aid for the Third-term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare
・Japan Agency for Medical Research and Development
JORTC
-KMP01
Efficacy of Rikkunshito on the Development and Progression of Cachexia in Gemcitabine-treated Pancreatic Cancer Patients ? Randomized Phase II Study Principal Investigator:
Yasuhito Uezono, M.D.,Ph.D.
National Cancer Center Research Insititute

Research Secretariat:
Shunsuke Ohnishi, M.D.,Ph.D.
Hokkaido University
Patients with unresectable pancreatic cancer who are going to be treated with gemcitabine completion
of
registration
UMIN
000008066
・Grants-in-Aid for the Third-term Comprehensive10-year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare
・Japan Agency for Medical Research and Development

* UMIN CTR is a Japanese clinical trial registration system operated by UMIN (University hospital Medical Information Network). UMIN CTR is approved by ICMJE (International Committee of Medical journal Editors).
http://www.umin.ac.jp/ctr/index-j.htm

Published:2012.12.03
Last updated:2018.02.25

 
 

This site complies with the HONcode standard for trustworthy health information: verify here.